Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 OCT 19 ... of people experiencing improved symptoms, when the drugs were compared to placebos. Anakinra was the least effective at just 6% improvement compared to placebos. The second measure ...
2009 OCT 19 ... A1C >7.5%, and BMI >27 kg/m(2) and were randomly assigned to receive 13 weeks of anakinra, a recombinant human IL-1Ra, or placebo, 67 completed treatment and were included in ...
2009 JUL 27 ... in Canada for the treatment of rheumatoid arthritis (RA): abatacept, adalimumab, anakinra, etanercept. infliximab, and rituxituab. Although they are generally considered to be ...
2009 JUN 29 ... research from the United States, "To report a case of probable anaphylaxis due to anakinra in a patient with rheumatoid arthritis and multiple drug allergies. SUMMARY: A ...
2009 JUN 29 ... Wisconsin, Medical College.
The researchers concluded: "Treatment with anakinra completely resolved the symptoms and lesions."
Reddy and colleagues ...
2009 JUN 1 ... to another conventional DMARD, addition of another conventional DMARD, addition of anakinra, or addition of a tumor necrosis factor (TNF) blocker. Presentation by pairs yielded 10 ...
2009 NOV 2 ... for use concomitantly with other biologic rheumatoid arthritis therapy, such as anakinra. The U.S. Food and Drug Administration approved on August 25, 2009, an ...
2009 APR 27 ... advantage over the existing treatment with the human IL-1 receptor antagonist anakinra, which must be injected daily and which is often poorly tolerated by patients," wrote ...
2009 OCT 12 ... stress and endothelial function with myocardial deformation, (b) the effects of anakinra, an interleukin-1a receptor antagonist on myocardial deformation in patients with ...
2009 NOV 9 ... arthritis, and the names of the individual DMARDs of interest (abatacept, adalimumab, anakinra, auranofin, aurothioglucose, aurothiomalate, D-penicillamine, etanercept, gold, ...
2009 MAY 4 ... the clinical response, safety, and tolerability of a single intraarticular injection of anakinra in patients with symptomatic osteoarthritis (OA) of the knee. Patients with OA of the ...
2009 NOV 1 ... with the potent anti-inflammatory cytokine interleukin-1 receptor antagonist (IL-1ra, anakinra). The patient had bouts of fever with peaking serum IL-6 concentrations followed by ...
2009 JUN 15 ... Puerto Rico. Those who were alive at the time of diagnosis—six in all—were treated with anakinra, a drug that is normally used for rheumatoid arthritis and is a synthetic form of human ...
Subject: NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases
2009 SEP 7 ... for use concomitantly with other biologic rheumatoid arthritis therapy, such as anakinra. The U.S. Food and Drug Administration approved on August 25, 2009, the ...
2009 OCT 5 ... to a number of marketed products, including interferon alfacon1, palifermin, anakinra and romiplostim. Before entering the biopharmaceutical industry, Dr. Miller completed a ...
